CBIC Notifies GST Rate change on Cancer Medicines and Namkeens as decided in Council Meeting:

CBIC has notified GST Rate change on Cancer Medicines and Namkeens as decided in the Council Meeting via issuing a notification.
GST Rate change on Cancer Medicines and Namkeens

“(233) Trastuzumab Deruxtecan (234) Osimertinib (235) Durvalumab”;
(b) in Schedule II – 6%, after S. No. 32B and the entries relating thereto, the following S. No. and entries shall be inserted, namely: -
(c) in Schedule III – 9%, -
(i) against S. No. 16, in column (3), for the words “un-fried or un-cooked snack pellets, by whatever name called, manufactured through a process of extrusion”, the words “un-fried or un-cooked snack pellets, by whatever name called, manufactured through a process of extrusion, extruded or expanded products, savoury or salted” shall be substituted;
(ii) for S. No. 435A and the entries relating thereto, the following S. No. and entries shall be substituted, namely: -
(d) in Schedule IV – 14%, after S. No. 210 and the entries relating thereto, the following S. No. and entries shall be inserted, namely: -
About Author
My Recent Articles
- Income Tax Guide for Indian Defence Personnel for Tax Filing, Taxable Allowances and Other Benefits
- Income Tax Return Breaking: ITR Forms released for AY 25-26
- Ex-DRT Officials Sentenced to 5 Years Rigorous Imprisonment by Madras High Court along with Rs.27 Lakh Fine
- GSTN issued Advisory on Case Sensitivity in IRN Generation
- RBI to issue Notes of Rs.10 and Rs.500 bearing Signature of Guv Malhotra
Loading suggestions…
Recent Posts

All Posts

Tags
No tags yet.
Recent Posts

All Posts

Tags
No tags yet.












